
Join to View Full Profile
Elm and Carlton StBuffalo, NY 14263
Phone+1 716-845-2300
Dr. Hassan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Hamza Hassan, MD, is a hematologist specializing in hematologic oncology based in Buffalo, NY. He completed his fellowship in Hematology and Medical Oncology at Boston University Medical Center and his residency in Internal Medicine at Rochester General Hospital. He obtained his medical degree from Rawalpindi Medical College in 2014. Dr. Hassan serves as an Assistant Professor at Roswell Park Comprehensive Cancer Center, a Research Fellow at Dana-Farber Cancer Institute, and an Instructor at Boston University School of Medicine. He has published research in prominent journals such as Bone Marrow Transplantation, Annals of Hematology, and Nature Cancer.
Education & Training
- Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
- Rawalpindi Medical CollegeClass of 2014
- Rochester General HospitalResidency, Internal Medicine
Certifications & Licensure
- NY State Medical License 2023 - 2026
- MA State Medical License 2019 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The Impact of Melphalan Conditioning and CD34Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan, Ute Hegenbart, Stefan Schönland
American Journal of Hematology. 2025-07-01 - Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody.Anam Ashfaque, Yara Shatnawi, Shahzad Raza, Diana Basali, Jack Khouri
Blood Reviews. 2025-05-09 - 1 citationsA model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis.Eli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, Hamza Hassan, Raphael Mwangi
Bone Marrow Transplantation. 2025-05-01
Lectures
- Role of investigational monoclonal antibodies in the treatment of multiple myeloma: A systematic review.2019 ASCO Annual Meeting - 6/1/2019
- Role of extra corporeal methods for light chain removal on renal recovery in multiple myeloma: A systematic review.2019 ASCO Annual Meeting - 6/1/2019
- Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: